NO810062L - Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering - Google Patents

Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering

Info

Publication number
NO810062L
NO810062L NO810062A NO810062A NO810062L NO 810062 L NO810062 L NO 810062L NO 810062 A NO810062 A NO 810062A NO 810062 A NO810062 A NO 810062A NO 810062 L NO810062 L NO 810062L
Authority
NO
Norway
Prior art keywords
preparing
procedure
long
pharmaceutical preparation
term release
Prior art date
Application number
NO810062A
Other languages
English (en)
Other versions
NO156153B (no
NO156153C (no
Inventor
James Michael Dunn
John Francis Lampard
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of NO810062L publication Critical patent/NO810062L/no
Publication of NO156153B publication Critical patent/NO156153B/no
Publication of NO156153C publication Critical patent/NO156153C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO810062A 1980-01-11 1981-01-09 Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering. NO156153C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (3)

Publication Number Publication Date
NO810062L true NO810062L (no) 1981-07-13
NO156153B NO156153B (no) 1987-04-27
NO156153C NO156153C (no) 1987-08-05

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810062A NO156153C (no) 1980-01-11 1981-01-09 Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering.

Country Status (22)

Country Link
JP (1) JPS56103110A (no)
AT (1) AT374681B (no)
AU (1) AU542824B2 (no)
BE (1) BE886998A (no)
CA (1) CA1140466A (no)
CH (1) CH646604A5 (no)
DE (1) DE3100191A1 (no)
DK (1) DK6181A (no)
ES (2) ES498369A0 (no)
FI (1) FI76927C (no)
FR (1) FR2473308B1 (no)
GB (1) GB2067072B (no)
GR (1) GR73843B (no)
IE (1) IE50806B1 (no)
IN (1) IN151913B (no)
IT (1) IT1221041B (no)
LU (1) LU83052A1 (no)
NL (1) NL8100037A (no)
NO (1) NO156153C (no)
NZ (1) NZ195933A (no)
SE (1) SE447450B (no)
ZA (1) ZA81136B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
EP0230647B1 (en) * 1985-12-27 1993-03-31 Sumitomo Pharmaceuticals Company, Limited Method for producing a sustained release formulation
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CA1316110C (en) * 1987-02-27 1993-04-13 Peter Lloyd Oren Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL265428A (no) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
NO156153B (no) 1987-04-27
FI76927C (fi) 1989-01-10
AU542824B2 (en) 1985-03-14
SE8100104L (sv) 1981-07-12
ATA5481A (de) 1983-10-15
NZ195933A (en) 1982-11-23
FR2473308A1 (fr) 1981-07-17
DK6181A (da) 1981-07-12
FI810056L (fi) 1981-07-12
AT374681B (de) 1984-05-25
ES509179A0 (es) 1982-12-16
AU6597681A (en) 1981-07-16
ES8205353A1 (es) 1982-06-01
IN151913B (no) 1983-09-03
DE3100191A1 (de) 1981-12-10
NL8100037A (nl) 1981-08-03
FR2473308B1 (fr) 1985-07-19
BE886998A (fr) 1981-07-08
FI76927B (fi) 1988-09-30
IE50806B1 (en) 1986-07-23
ES498369A0 (es) 1982-06-01
NO156153C (no) 1987-08-05
GB2067072A (en) 1981-07-22
IT8147537A0 (it) 1981-01-09
LU83052A1 (fr) 1982-09-10
ES8301629A1 (es) 1982-12-16
GB2067072B (en) 1983-08-10
IE810036L (en) 1981-07-11
DE3100191C2 (no) 1988-09-01
SE447450B (sv) 1986-11-17
ZA81136B (en) 1982-01-27
GR73843B (no) 1984-05-07
IT1221041B (it) 1990-06-21
JPS56103110A (en) 1981-08-18
CA1140466A (en) 1983-02-01
CH646604A5 (fr) 1984-12-14

Similar Documents

Publication Publication Date Title
DK221281A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forbedrede frigivelsesegenskaber
NO812827L (no) Fremgangsmaate for fremstilling av et bacampicillinpreparat
NO173213C (no) Fremgangsmaate for fremstilling av et preparat omfattende et liposom
NO882103D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO781079L (no) Preparat med regulert medikamentfrigjoering
FI801876A (fi) Farmaceutiska preparat
DK146677A (da) Fremgangsmade til fremstilling af et farmaceutisk preparat indeholdende triazolopyrimidin
DK151608C (da) Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK584676A (da) Fremgangsmade til fremstilling af et stabilt antibiotisk preparat
DK153440C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
DK588476A (da) Fremgangsmade til fremstilling af et oralt administrerbart farmaceutisk preparat
DK160739C (da) Fremgangsmaade til fremstilling af et stabilt prostaglandinindeholdende praeparat til laegemiddelanvendelse
NO810062L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering
NO934897L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
DK528879A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende isosorbiddinitrat
NO870368L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig virkning.
NO822749L (no) Fremgangsmaate for fremstilling av et karbostyrilderivat
NO824112L (no) Fremgangsmaate for fremstilling av et fluorbiprofenderivat
DK98076A (da) Fremgangsmade til fremstilling af et farmaceutisk preparat
DK155082A (da) Fremgangsmaade til fremstilling af et praeparat med cytotoxisk virkning
DK7679A (da) Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat
DK206582A (da) Fremgangsmaade til fremstilling af et furanderivat
DK471181A (da) Fremgangsmaade til fremstilling af et pyrimidinderivat
FI810874L (fi) Farmaceutiska preparat
DK159136C (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat til rectal indgivning